Sirolimus-eluting stents are more effective than bare stents for the prevention of coronary artery restenosis in patients with de novo lesions

By  

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Treatment with sirolimus-eluting stents is effective in patients with unprotected left main coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite